| RS1603283567 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603285352 |
SHOX
|
Health Risk |
Conflicting classifications of pathogenicity |
SHOX-related short stature, SHOX-related short stature |
| RS1603286090 |
TCF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1603286154 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603287481 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1603287820 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603288794 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1603288815 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603288832 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603288875 |
CHM
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1603289772 |
NAA10
|
Health Risk |
Likely pathogenic |
Microphthalmia, syndromic 1 |
| RS1603289774 |
NAA10
|
Health Risk |
Pathogenic/Likely pathogenic |
Microphthalmia, syndromic 1 |
| RS1603290097 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290131 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290148 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290169 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290199 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290291 |
NAA10
|
Health Risk |
Likely pathogenic |
Ogden syndrome, Ogden syndrome |
| RS1603290366 |
NAA10
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1603290681 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS1603290763 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290796 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603290816 |
NAA10
|
Health Risk |
Likely pathogenic |
Ogden syndrome, Ogden syndrome |
| RS1603291770 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603292021 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603292081 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1603292422 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603293306 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603293314 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603293553 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603293570 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603293605 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603293624 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603293639 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603297223 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1603297305 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603297334 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603297903 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS1603298378 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603298803 |
PHF8
|
Health Risk |
Pathogenic |
— |
| RS1603298869 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603298993 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603305030 |
PHF8
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Siderius type, Syndromic X-linked intellectual disability Siderius type |
| RS1603306716 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603306718 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603307453 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS1603307604 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603307859 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603307865 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603307876 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS1603308066 |
UBE2A
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Nascimento type, Syndromic X-linked intellectual disability Nascimento type |
| RS1603308287 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603308308 |
SRY
|
Health Risk |
Pathogenic |
46, XY sex reversal 1 |
| RS1603308358 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Inborn genetic diseases |
| RS1603308957 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603308963 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603309190 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603309480 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603309620 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, Rett syndrome |
| RS1603310370 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603310380 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603310755 |
MECP2
|
Health Risk |
Pathogenic |
Autism, susceptibility to |
| RS1603310794 |
MECP2
|
Health Risk |
Pathogenic |
Severe neonatal-onset encephalopathy with microcephaly, Severe neonatal-onset encephalopathy with microcephaly |
| RS1603310863 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS1603310867 |
MECP2
|
Health Risk |
Likely pathogenic |
12 conditions, 12 conditions |
| RS1603310910 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS1603311030 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603314287 |
PHF8
|
Health Risk |
Pathogenic |
— |
| RS1603318143 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603318154 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603319726 |
CD40LG
|
Health Risk |
Likely pathogenic |
— |
| RS1603321138 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1603321148 |
CD40LG
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1603321154 |
CD40LG
|
Health Risk |
Likely pathogenic |
— |
| RS1603321772 |
CD40LG
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1603321834 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1603321840 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1603323174 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603323278 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603323355 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603323412 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603326397 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603326561 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603326578 |
THOC2
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability-short stature-overweight syndrome, X-linked intellectual disability-short stature-overweight syndrome |
| RS1603328025 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603328372 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603328406 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603328466 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Gastric cancer |
| RS1603328667 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603328780 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603328816 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1603328913 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603328999 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603334464 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1603334619 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603334758 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603336347 |
IRS4
|
Health Risk |
Pathogenic |
Hypothyroidism, congenital |
| RS1603336895 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603336897 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603336980 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |